{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Iridium_Ir_192",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A radioactive isotope of iridium. Iridium-192 emits gamma rays and has a half-life of 74 days. A high dose rate of this radioisotope can be used in brachytherapy to treat tumors by selectively delivering a cytotoxic dose of radiation to the tumor site.",
    "fdaUniiCode": "064LI0IBFL",
    "identifier": "C104270",
    "preferredName": "Iridium Ir 192",
    "semanticType": "Indicator, Reagent, or Diagnostic Aid",
    "subclassOf": [
      "C799"
    ],
    "synonyms": [
      "IRIDIUM IR-192",
      "Ir-192",
      "Iridium Ir 192",
      "Iridium-192"
    ]
  }
}